GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC18869 structure
    GC18869Deoxyenterocin
    CAS: 108605-51-2
    Purity: >98%

    Deoxyenterocin is a bacterial metabolite originally isolated from Streptomyces that has diverse biological activities, including antibiotic, antiviral, and antioxidant properties.

  • GC18874 structure
    GC18874Prostaglandin F2α serinol amide
    CAS: 1135226-99-1

    A stable analog of PGF 2α 2glyceryl ester

  • GC18877 structure
    GC18877CAY10606
    CAS: 1159576-98-3
    Purity: >98%

    5-Lipoxygenase (5-LO) initiates the synthesis of leukotrienes (LTs) from arachidonic acid, primarily in certain leukocyte populations.

  • GC18883 structure
    GC18883CAY10614
    CAS: 1202208-36-3
    Purity: >98%

    CAY10614 est un puissant antagoniste du TLR4.

  • GC18887 structure
    GC18887CAY10640
    CAS: 1208549-68-1
    Purity: >98%

    CAY10640 (composé TCPU) est un inhibiteur actif puissant et oral de sEH (époxyde hydrolase soluble) avec des IC50 de 0,4 et 5,3 nM chez l'humain et le murin, respectivement.

  • GC18895 structure
    GC18895NIBR0213
    CAS: 1233332-14-3
    Purity: >98.00%

    NIBR-0213 est un antagoniste S1P1 puissant et sélectif, efficace dans l'encéphalomyélite auto-immune expérimentale.

  • GC18900 structure
    GC18900L-156,602
    CAS: 125228-51-5
    Purity: >98%

    L-156,602 is an antagonist of the complement component 5A (C5a) receptor (IC50 = 1.7 ug/L in a radioligand binding assay using neutrophil membranes).

  • GC18902 structure
    GC18902Heronamide C
    CAS: 1257083-94-5
    Purity: >98%

    Heronamide C is a polyketide macrolactam antifungal agent produced by marine Actinomycetes.

  • GC18904 structure
    GC18904CAY10678
    CAS: 1268709-57-4
    Purity: >98.00%

    Microsomal prostaglandin E synthase-1 (mPGES-1) converts the COX product PGH2 into the biologically active PGE2.

  • GC18908 structure
    GC18908Viridicatin
    CAS: 129-24-8
    Purity: >98%

    La viridicatine est un métabolite fongique de l'espèce Penicillium.

  • GC18910 structure
    GC18910CAY10654
    CAS: 1298023-69-4
    Purity: >98%

    The gram-negative pathogen Pseudomonas aeruginosa uses N-acylated-L-homoserine lactones (AHLs) in quorum sensing to modulate transcriptional activators, including LasR, and regulate the expression of virulence factors.

  • GC18921 structure
    GC18921tetranor-PGJM
    CAS: 1352751-83-7
    Purity: >98%

    Prostaglandin D2 (PGD2) plays a pharmacological role in allergic and asthmatic anaphylaxis, normal physiological sleep and lowering of body temperature, as well as inhibits platelet aggregation and relaxes vascular smooth muscle.

  • GC18922 structure
    GC18922Camalexin
    CAS: 135531-86-1
    Purity: >99.50%

    Camalexin est une phytoalexine alcaloïde dérivées du tryptophane chez Arabidopsis thaliana, possédant une activité antimicorbienne.

  • GC18923 structure
    GC18923URB937
    CAS: 1357160-72-5
    Purity: >98.00%

    URB937 est un inhibiteur sélectif, oralement actif et à action restreinte à la périphérie, de l' amide hydrolase des acides gras (FAAH) avec une IC 50 de 26.8nM.

  • GC18936 structure
    GC18936A-83016F
    CAS: 142435-72-1
    Purity: >98%

    A-83016F is an aurodox antibiotic isolated from the actinomycete species A83016.

  • GC18955 structure
    GC18955Reveromycin C
    CAS: 144860-69-5
    Purity: >98%

    Reveromycin C is a polyketide originally isolated from Streptomyces that has antifungal activity against C.

  • GC18964 structure
    GC18964Palitantin
    CAS: 15265-28-8
    Purity: >98%

    La palitantine ((±)-palitantine), un métabolite de Penicillium frequentans sur Leishmania brasiliensis, a un effet antiprotozoaire contre Leishmania brasiliensis.

  • GC18978 structure
    GC18978Aspartocin D
    CAS: 1562369-96-3
    Purity: >98%

    Aspartocin D is a lipopeptide antibiotic originally isolated from S.

  • GC18984 structure
    GC18984Saccharocarcin B
    CAS: 158475-33-3
    Purity: >98%

    Saccharocarcin B is a macrocyclic lactone antibiotic that is active against the Gram-positive bacteria M.

  • GC18988 structure
    GC18988ML RR-S2 CDA (ammonium salt)
    CAS: 1638750-96-5
    Purity: >98.00%

    ML RR-S2 CDA (sel d'ammonium) (sel d'ammonium MIW815), un activateur du stimulateur des gènes de l'interféron (STING), conduit À une régression tumorale et À une immunité puissantes et systémiques.

  • GC19001 structure
    GC19001Tetromycin B
    CAS: 180027-84-3
    Purity: >98%

    Tetromycin B is a cysteine protease inhibitor with Ki values of 0.62, 1.42, 32.5, and 1.59 μM for rhodesain, falcipain-2, cathepsin L, and cathepsin B, respectively.

  • GC19002 structure
    GC19002Penigequinolone A
    CAS: 180045-91-4
    Purity: >98%

    Penigequinolone A is an alkaloid isolated from Penicillium.

  • GC19008 structure
    GC19008Leucomycin A5
    CAS: 18361-45-0
    Purity: >98%

    Leucomycin A5 is a metabolite from the leucomycin complex, which was originally isolated from S.

  • GC19046 structure
    GC19046AX-024 hydrochloride
    CAS: 1704801-24-0
    Purity: >99.00%

    Le chlorhydrate d'AX-024 est un inhibiteur de premier ordre disponible par voie orale de l'interaction TCR-Nck qui inhibe sélectivement l'activation des lymphocytes T déclenchée par le TCR avec une IC50 ~ 1 nM.